Evaluation of right ventricular function in patients with COPD

Respiratory Care

Volumn 58, Issue 5, 2013, Pages 816-823

  Tanaka, Yosuke ^a   Hino, Mitsunori ^a   Mizuno, Kyoichi ^a   Gemma, Akihiko ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Chronic obstructive respiratory disease; Circulation; Echocardiography; Heart failure; Pulmonary hypertension; Right ventricular function

Indexed keywords

AGED; CARDIOVASCULAR PARAMETERS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART CONTRACTION; HEART RIGHT VENTRICLE EJECTION TIME; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE ISOVOLUMETRIC CONTRACTION TIME; HEART RIGHT VENTRICLE ISOVOLUMETRIC RELAXATION TIME; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SURVIVAL RATE; TOTAL EJECTION ISOVOLUME INDEX; TOTAL LUNG CAPACITY;

ACTIVITIES OF DAILY LIVING; AGED; BODY HEIGHT; BODY WEIGHT; DYSPNEA; ECHOCARDIOGRAPHY, DOPPLER, COLOR; HUMANS; HYPERTENSION, PULMONARY; MALE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VENTRICULAR FUNCTION, RIGHT;

EID: 84876833480     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01856     Document Type: Review

References (42)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555.
2. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
3. Rutten-van Mölken M, Roos B, Van Noord JA. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 1999;54(11):995-1003.
4. Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995;107(5):1193-1198.
5. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducoloné A, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172(2):189-194.
6. Bagnato GF, Mileto A, Gulli S, Piscioneri S, Romano C, Giacobbe O, et al. Non invasive assessment of cardiac function in patients with bronchial asthma (BA) or chronic obstructive pulmonary disease (COPD). Allergol Immunopathol (Madr) 1999;27(1):5-10.
7. Vonk MC, Sander MH, van den Hoogen FH, van Riel PL, Verheugt FW, van Dijk AP. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr 2007;8(5): 317-321.
8. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23(7):685-713.
9. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, Tajik AJ, Seward SB. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996;9(6):838-847.
10. Yamaguchi K, Miyahara Y, Yakabe K, Kiya T, Nakatomi M, Shikuwa M, Kohno S. Right ventricular impairment in patients with chronic respiratory failure on home oxygen therapy: non-invasive assessment using a new Doppler index. J Int Med Res 1998;26(5): 239-247.
11. Nishimura E, Ikeda S, Naito T, Yamaguchi K, Yakabe K, Iwasaki T, et al. Evaluation of right-ventricular function by Doppler echocardiography in patients with chronic respiratory failure. J Int Med Res 1999;27(2):65-73.
12. Ferrer MI. Clinical and electrocardiographic correlations in pulmonary heart disease (cor pulmonale). Cardiovasc Clin 1977;8(3):215-224.
13. Okamoto M, Miyatake K, Kinoshita N, Sakakibara H, Nimura Y. Analysis of blood flow in pulmonary hypertension with the pulsed Doppler flowmeter combined with cross sectional echocardiography. Br Heart J 1984;51(4):407-415.
14. Graettinger WF, Greene ER, Voyles WF. Doppler predictions of pulmonary artery pressure, flow, and resistance in adults. Am Heart J 1987;113(6):1426-1437.
15. Serra W, Chetta A, Santilli D, Mozzani F, Dall'Aglio PP, Olivieri D, et al. Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis. Cardiovasc Ultrasound 2010;8:25.
16. Barthlen GM. Sleep disorders. Obstructive sleep apnea syndrome, restless legs syndrome, and insomnia in geriatric patients. Geriatrics 2002;57(11):34-39.
17. Polo-Kantola P. Sleep problems in midlife and beyond. Maturitas 2011;68(3):224-232.
18. Whitmore S, Chiodi H. Progesterone, pulmonary hyperventilation, and cirrhosis. Ann Intern Med 1972;77(2):326-327.
19. Bonekat HW, Dombovy ML, Staats BA. Progesterone-induced changes in exercise performance and ventilatory response. Med Sci Sports Exerc 1987;19(2):118-123.
20. Dombovy ML, Bonekat HW, Williams TJ, Staats BA. Exercise performance and ventilatory response in the menstrual cycle. Med Sci Sports Exerc 1987;19(2):111-117.
21. Robertson HT, Schoene RB, Pierson DJ. Augmentation of exercise ventilation by medroxyprogesterone acetate. Clin Physiol 1982;2(4): 269-276.
22. Mikami M, Tatsumi K, Kimura H, Honda Y, Kuriyama T. Respiration effect of synthetic progestin in small doses in normal men. Chest 1989;96(5):1073-1075.
23. Saaresranta T, Polo O. Hormones and breathing. Chest 2002;122(6): 2165-2182.
24. Bastarache JA, Diamond JM, Kawut SM, Lederer DJ, Ware LB, Christie JD. Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients. Gend Med 2012;9(3):154-165.
25. Gabler NB, French B, Strom BL, Liu Z, Palevsky HI, Taichman DB, et al. Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. Chest 2012;141(1): 20-26.
26. Kawut SM, Lima JA, Barr RG, Chahal H, Jain A, Tandri H, et al. Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study. Circulation 2011;123(22):2542-2551.
27. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-586.
28. Krowka MJ. Pulmonary hypertension: diagnostics and therapeutics. Mayo Clin Proc 2000;75(6):625-630.
29. McGoon MD, Fuster V, Freeman WK, Edwards WD, Scott JP. Pulmonary hypertension. In: Giuliani ER, Gersh BJ, McGoon MD, Hayes DL, Schaff HV, editors. Mayo Clinic practice of cardiology, 3rd edition. St Louis: Mosby; 1996:1815-1836.
30. Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC Jr. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 2002;122(2):524-527.
31. Naeije R, Torbicki A. More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J 1995;8(9):1445-1449.
32. Schiller NB. Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol Clin 1990;8(2):277-287.
33. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984;70(4):657-662.
34. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S55-S66.
35. Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti A, Santoro G, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000;101(24):2817-2822.
36. Wasserman K, Whipp BJ, Koyl SN, Beaver WL. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol 1973;35(2):236-243.
37. Davis JA, Vodak P, Wilmore JH, Vodak J, Kurtz P. Anaerobic threshold and maximal aerobic power for three modes of exercise. J Appl Physiol 1976;41(4):544-550.
38. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998;113(3):576-583.
39. Jessup M, Sutton MS, Weber KT, Janicki JS. The effect of chronic pulmonary hypertension on left ventricular size, function, and interventricular septal motion. Am Heart J 1987;113(5):1114-1122.
40. Schena M, Clini E, Errera D, Quadri A. Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest 1996; 109(6):1446-1451.
41. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362(3):217-227.
42. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348(21): 2059-2073.